CancerInfo Center
Targeting HER2 in Lung Cancer
You may have heard of HER2-positive breast cancer. You may not know that this gene can also play a role in lung cancer. And anti-HER2 medications may be useful in treating the world’s most common cancer.
Price of Fame at the Expense of Longer Life
Success and fame can come with a hefty price: living a shorter life. Researchers said fame and achievements in performance-related careers could come at the cost of a shorter life expectancy.
Genes Make the Cancer Difference
Scientists are continuing to discover that the location of a cancer isn’t the whole story. The genetic make-up of the tumors makes a huge difference in how the cancer behaves and how it can be treated.
More Advanced Cancer in Medicaid Patients
Rates of cancers that develop in the head and neck are growing in the United States and around the world. In part, this increase can be blamed on the human papillomavirus.
Success of the Free HPV Vaccine
It's icing on the cake when a vaccine is offered for little to no cost. Free human papilloma virus (HPV) vaccine programs can protect many individuals from genital warts without draining their bank accounts.
Better to Toss the Tonsils First
Tonsils are located on either side of the back of throat. They are part of the immune system, but not critical for good health. Today, cancers found in the tonsils are the most common type of head and neck cancer.
Pricking and Pulsing Tumors to Death
Cancer tumors are in the business of surviving and growing. And they’re pretty good at it. Their tenacity may be put to the test before too long with a novel therapy that pokes and pricks and pulses them into tumor heaven.
The Languages of Skin Cancer Prevention
Hispanics don’t develop skin cancer at the same rate Caucasians do. But that doesn't mean Hispanics are immune from skin cancer. Practicing skin cancer prevention is important for everyone, regardless of culture or spoken language.
PSA Test Outcomes Vary for Older Men
While the incidence of prostate cancer is greater in older men, the screening guidelines are murky. A new study analyzed what happened after older men were screened.
A Crystal Ball for Prostate Cancer Testing
The statistics are pretty clear that most American men are not going to die of prostate cancer. But the question remains: who should be screened and how often? A new crystal ball may be on the horizon.